Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification
European Journal of Surgical Oncology · 2026-09 · 52 (9) · 112031
DOI: 10.1016/j.ejso.2026.112031 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-09. Verfasst von Yuxuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Labora…. Hauptthemen laut MEDLINE: Gallbladder Neoplasms. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: In the AJCC 8th edition, N2M0 and M1 gallbladder cancer (GBC) are classified into Stage IVB, leading clinicians to treat them identically. This study separates N2M0 from M1 disease, re-evaluating chemotherapy, surgical quality, and establishing a clinical risk stratification system (CRSS). MATERIALS AND METHODS: Stage IVB GBC patients (2000-2022) were identified from the SEER database. A 1:3 propensity score matching (PSM) balanced N2M0 and M1 baseline characteristics. Overall survival was compared, optimal lymph node ratio (LNR) was identified, and the prediction model internally verified using 1000 bootstrap resamples. RESULTS: From 7270 initial IVB patients, PSM matched 125 N2M0 and 343 M1 patients. N2M0 patients demonstrated superior median overall survival versus M1 patients (17 vs. 9 months, P = 0.001). However, this survival advantage depended entirely on adjuvant chemotherapy. Untreated N2M0 patients had a worse prognosis than treated M1 patients (P = 0.002). For N2M0 patients, extended multi-organ resection offered no survival benefit over standard radical cholecystectomy (HR = 0.724, P = 0.225). A lower LNR (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
- Department of General Surgery, Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China. Electronic ad…
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Chen, Y., Chen, S., He, K., Zhao, X., Yang, Y., Zhu, Y., & Wu, X. (2026). Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification. European Journal of Surgical Oncology, 52(9), 112031. https://doi.org/10.1016/j.ejso.2026.112031
Vancouver
Chen Y, Chen S, He K, Zhao X, Yang Y, Zhu Y, et al. Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification. European Journal of Surgical Oncology. 2026;52(9):112031. doi:10.1016/j.ejso.2026.112031
BibTeX
@article{Chen2026,
author = {Chen, Yuxuan and Chen, Shiyu and He, Kaiju and Zhao, Xiang and Yang, Yue and Zhu, Yidi and Wu, Xiangsong},
title = {Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
number = {9},
pages = {112031},
doi = {10.1016/j.ejso.2026.112031}
}
EUVIMED